Geovax Labs Inc (GOVX)
2.935
+0.24
(+8.70%)
USD |
NASDAQ |
Nov 22, 16:00
2.91
-0.02
(-0.85%)
After-Hours: 20:00
Geovax Labs Cash from Operations (Quarterly): -9.297M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -9.297M |
| June 30, 2024 | -1.941M |
| March 31, 2024 | -5.684M |
| December 31, 2023 | -10.28M |
| September 30, 2023 | -5.096M |
| June 30, 2023 | -6.037M |
| March 31, 2023 | -3.763M |
| December 31, 2022 | -7.064M |
| September 30, 2022 | -3.799M |
| June 30, 2022 | -3.834M |
| March 31, 2022 | -4.333M |
| December 31, 2021 | -6.683M |
| September 30, 2021 | -1.634M |
| June 30, 2021 | -1.258M |
| March 31, 2021 | -1.621M |
| December 31, 2020 | -1.542M |
| September 30, 2020 | -0.2831M |
| June 30, 2020 | -0.5669M |
| March 31, 2020 | -0.3586M |
| December 31, 2019 | -0.2808M |
| September 30, 2019 | -0.3439M |
| June 30, 2019 | -0.4564M |
| March 31, 2019 | -0.3174M |
| December 31, 2018 | -0.5015M |
| September 30, 2018 | -0.2797M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.3802M |
| March 31, 2018 | -0.3816M |
| December 31, 2017 | -0.4484M |
| September 30, 2017 | -0.4788M |
| June 30, 2017 | -0.4292M |
| March 31, 2017 | -0.3321M |
| December 31, 2016 | -0.3684M |
| September 30, 2016 | -0.4033M |
| June 30, 2016 | -0.5454M |
| March 31, 2016 | -0.6291M |
| December 31, 2015 | -0.7607M |
| September 30, 2015 | -0.6547M |
| June 30, 2015 | -0.671M |
| March 31, 2015 | -0.6189M |
| December 31, 2014 | -0.6339M |
| September 30, 2014 | -0.4853M |
| June 30, 2014 | -0.6274M |
| March 31, 2014 | -0.5035M |
| December 31, 2013 | -0.8226M |
| September 30, 2013 | -0.0742M |
| June 30, 2013 | -0.4534M |
| March 31, 2013 | -0.3445M |
| December 31, 2012 | -0.5479M |
| September 30, 2012 | -0.2332M |
| June 30, 2012 | -0.4235M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.28M
Minimum
Dec 2023
-0.2808M
Maximum
Dec 2019
-3.768M
Average
-3.781M
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 2.705B |
| Emergent BioSolutions Inc | 153.70M |
| Tonix Pharmaceuticals Holding Corp | -18.80M |
| SIGA Technologies Inc | -7.384M |
| Chimerix Inc | -20.51M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0207M |
| Cash from Financing (Quarterly) | 16.35M |
| Free Cash Flow | -27.24M |
| Free Cash Flow Per Share (Quarterly) | -1.455 |
| Free Cash Flow to Equity (Quarterly) | -9.176M |
| Free Cash Flow Yield | -279.3% |